15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE2/EP4 in T2DM mice-Reference-Cited by-同舟云学术

15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE2/EP4 in T2DM mice

Published:2023-08 Issue: Volume:137 Page:106646
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Wang Weixuan,Liang Mingjie,Wang Lexun,Bei Weijian,Guo Jiao

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference79 articles.

1. Type 2 diabetes;Chatterjee;Lancet,2017

2. Type 2 diabetes mellitus;DeFronzo;Nat. Rev. Dis. Primers,2015

3. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045;Sun;Diabetes Res. Clin. Pract.,2022

4. New insights into ER stress-induced insulin resistance;Flamment;Trends Endocrinol Metab,2012

5. Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine;Guo;Chin. J. Integr. Med.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico screening and in vivo experimental validation of 15-PGDH inhibitors from traditional Chinese medicine promoting liver regeneration;International Journal of Biological Macromolecules;2024-08

2. ATR induces hepatic lipid metabolism disorder in rats by activating IRE1α/XBP1 signaling pathway;Toxicology;2024-01

3. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism;Open Life Sciences;2024-01-01